Scraping Assay as a Novel Strategy to Evaluate Axonal Regeneration Using Human-Induced Pluripotent Stem Cell-Derived Neurons

被引:0
作者
Oonishi, Tomu [1 ]
Nishimura, Kaneyasu [2 ]
Takata, Kazuyuki [3 ]
Fujimuro, Masahiro [1 ]
Sekine, Yuichi [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Cell Biol, 1 Misasagishichono Cho,Yamashina Ku, Kyoto 6078412, Japan
[2] Doshisha Univ, Grad Sch Brain Sci, Lab Funct Brain Circuit Construct, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100394, Japan
[3] Kyoto Pharmaceut Univ, Div Integrated Pharmaceut Sci, 5 Nakauchi Cho,Yamashina Ku, Kyoto 6078414, Japan
关键词
axonal regeneration; human-induced pluripotent stem cell-derived neuron; in vitro screening system; NEURITE OUTGROWTH; NOGO-A; INHIBITOR; GLYCOPROTEIN; RECEPTOR; SCREEN; CNS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuronal regrowth after traumatic injury is strongly inhibited in the central nervous system (CNS) of adult mammals. Cell -intrinsic and extrinsic factors limit the regulation of axonal growth and regrowth of fibers is minimal despite nearly all neurons surviving. Developing medical drugs to promote neurological recovery is crucial since neuronal injuries have few palliative cares and no pharmacological interventions. Herein, we developed a novel in vitro axonal regeneration assay system to screen the chemical reagents using human -induced pluripotent stem cell (hiPSC)-derived neurons. These neurons were cultured in a 96 -well plate to form a monolayer and were scraped using a floating metal pin tool for axotomy. The cell number and plate coating conditions were optimized to score the regenerating axon. Treatment using the Rho -associated kinase (ROCK) inhibitor Y-27632 enhanced axonal regeneration in this regeneration assay system with hiPSC-derived neurons. Therefore, our novel screening method is suitable for drug screening to identify the chemical compounds that promote axonal regeneration after axotomy under in vitro conditions.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 24 条
[1]   In vitro models of axon regeneration [J].
Al-Ali, Hassan ;
Beckerman, Samuel R. ;
Bixby, John L. ;
Lemmon, Vance P. .
EXPERIMENTAL NEUROLOGY, 2017, 287 :423-434
[2]   Electrical Responses and Spontaneous Activity of Human iPS-Derived Neuronal Networks Characterized for 3-month Culture with 4096-Electrode Arrays [J].
Amin, Hayder ;
Maccione, Alessandro ;
Marinaro, Federica ;
Zordan, Stefano ;
Nieus, Thierry ;
Berdondini, Luca .
FRONTIERS IN NEUROSCIENCE, 2016, 10
[3]   Laser-Induced Axotomy of Human iPSC-Derived and Murine Primary Neurons Decreases Somatic Tau and AT8 Tau Phosphorylation: A Single-Cell Approach to Study Effects of Acute Axonal Damage [J].
Bell-Simons, M. ;
Buchholz, S. ;
Klimek, J. ;
Zempel, H. .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (07) :3497-3510
[4]   Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 [J].
Chen, MS ;
Huber, AB ;
van der Haar, ME ;
Frank, M ;
Schnell, L ;
Spillmann, AA ;
Christ, F ;
Schwab, ME .
NATURE, 2000, 403 (6768) :434-439
[5]   Rho kinase inhibition enhances axonal regeneration in the injured CNS [J].
Fournier, AE ;
Takizawa, BT ;
Strittmatter, SM .
JOURNAL OF NEUROSCIENCE, 2003, 23 (04) :1416-1423
[6]   Axon growth inhibition by RhoA/ROCK in the central nervous system [J].
Fujita, Yuki ;
Yamashita, Toshihide .
FRONTIERS IN NEUROSCIENCE, 2014, 8
[7]   Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein [J].
GrandPré, T ;
Nakamura, F ;
Vartanian, T ;
Strittmatter, SM .
NATURE, 2000, 403 (6768) :439-444
[8]   A Multi-domain Fragment of Nogo-A Protein Is a Potent Inhibitor of Cortical Axon Regeneration via Nogo Receptor 1 [J].
Huebner, Eric A. ;
Kim, Byung G. ;
Duffy, Philip J. ;
Brown, Rebecca H. ;
Strittmatter, Stephen M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (20) :18026-18036
[9]  
Inoue S, 2023, BIOL PHARM BULL, V46, P517, DOI 10.1248/bpb.b22-00839
[10]   Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth [J].
Kottis, V ;
Thibault, P ;
Mikol, D ;
Xiao, ZC ;
Zhang, R ;
Dergham, P ;
Braun, PE .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1566-1569